نتایج جستجو برای: lrrk2 inhibitors

تعداد نتایج: 189958  

2016
Corinna Bliederhaeuser Lisa Zondler Veselin Grozdanov Wolfgang P. Ruf David Brenner Heather L. Melrose Peter Bauer Albert C. Ludolph Frank Gillardon Jan Kassubek Jochen H. Weishaupt Karin M. Danzer

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common cause of familial Parkinson’s disease (PD) [20, 32]. Common polymorphisms in LRRK2 have been shown to modulate the risk for sporadic PD [6, 23, 24] strengthening the idea that inherited and sporadic PD share common underlying pathways. Although LRRK2 has been associated with a variety of cellular functions, including...

2006
Wanli W Smith Zhong Pei Haibing Jiang Valina L Dawson Ted M Dawson Christopher A Ross

Mutations in the the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease. Here we found that LRRK2 kinase activity was regulated by GTP via the intrinsic GTPase Roc domain, and alterations of LRRK2 protein that reduced kinase activity of mutant LRRK2 correspondingly reduced neuronal toxicity. These data elucidate the ...

Journal: :Molecular and cellular biology 2014
Giovanni Piccoli Franco Onofri Maria Daniela Cirnaru Christoph J O Kaiser Pravinkumar Jagtap Andreas Kastenmüller Francesca Pischedda Antonella Marte Felix von Zweydorf Andreas Vogt Florian Giesert Lifeng Pan Flavia Antonucci Christina Kiel Mingjie Zhang Sevil Weinkauf Michael Sattler Carlo Sala Michela Matteoli Marius Ueffing Christian Johannes Gloeckner

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are associated with familial and sporadic Parkinson's disease (PD). LRRK2 is a complex protein that consists of multiple domains, including predicted C-terminal WD40 repeats. In this study, we analyzed functional and molecular features conferred by the WD40 domain. Electron microscopic analysis of the purified LRRK2 C-terminal domain re...

2015
Dejun Yang Sharmila Das Loujing Song Tianxia Li Jianqun Yan Wanli W. Smith

Parkinson’s disease (PD) is a common neurodegenerative disease with unclear pathogenesis. Currently, there are no disease-modifying neuron-protecting drugs to slow down the neuronal degeneration. Mutations in the leucine-rich repeat kinase 2 (LRRK2) cause genetic forms of PD and contribute to sporadic PD as well. Disruption of LRRK2 kinase functions has become one of the potential mechanisms un...

2015
Claustre Pont-Sunyer Alex Iranzo Carles Gaig Ana Fernández-Arcos Dolores Vilas Francesc Valldeoriola Yaroslau Compta Ruben Fernández-Santiago Manel Fernández Angels Bayés Matilde Calopa Pilar Casquero Oriol de Fàbregues Serge Jaumà Victor Puente Manel Salamero Maria José Martí Joan Santamaría Eduard Tolosa Andrea Romigi

OBJECTIVE In idiopathic Parkinson disease (IPD) sleep disorders are common and may antedate the onset of parkinsonism. Based on the clinical similarities between IPD and Parkinson disease associated with LRRK2 gene mutations (LRRK2-PD), we aimed to characterize sleep in parkinsonian and nonmanifesting LRRK2 mutation carriers (NMC). METHODS A comprehensive interview conducted by sleep speciali...

2014
Elena Popugaeva Ilya Bezprozvanny

Parkinson’s disease (PD) is the most common form of age related motor disorder (Hsu et al., 2010; Ferree et al., 2012). Mutations in leucine-rich repeat kinase 2, LRRK2, gene are considered to be genetic determinants of PD. Among them G2019S is the most prevalent amino acid substitution mutation in LRRK2 and accounts for 1–2% of sporadic PD cases (Healy et al., 2008). LRRK2 is involved in many ...

Journal: :Human molecular genetics 2012
Elena V Nikonova Yulan Xiong Keith Q Tanis Valina L Dawson Robert L Vogel Eva M Finney David J Stone Ian J Reynolds Jonathan T Kern Ted M Dawson

Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) are the most common genetic cause of Parkinson's disease (PD) and cause both autosomal dominant familial and sporadic PD. Currently, the physiological and pathogenic activities of LRRK2 are poorly understood. To decipher the biological functions of LRRK2, including the genes and pathways modulated by LRRK2 kinase activity in vivo, we as...

2011
Cathrin Schulz Marie Paus Katharina Frey Ramona Schmid Zacharias Kohl Detlev Mennerich Jürgen Winkler Frank Gillardon

BACKGROUND Dominant mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most prevalent cause of Parkinson's disease, however, little is known about the biological function of LRRK2 protein. LRRK2 is expressed in neural precursor cells suggesting a role in neurodevelopment. METHODOLOGY/PRINCIPAL FINDINGS In the present study, differential gene expression profiling revealed a fas...

Journal: :Human molecular genetics 2012
Mark W Dodson Ting Zhang Changan Jiang Shengdi Chen Ming Guo

LRRK2 (PARK8) is the most common genetic determinant of Parkinson's disease (PD), with dominant mutations in LRRK2 causing inherited PD and sequence variation at the LRRK2 locus associated with increased risk for sporadic PD. Although LRRK2 has been implicated in diverse cellular processes encompassing almost all cellular compartments, the precise functions of LRRK2 remain unclear. Here, we sho...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2010
Seongsoo Lee Hsin-Ping Liu Wei-Yong Lin Huifu Guo Bingwei Lu

Mutations in leucine-rich repeat kinase 2 (LRRK2) are linked to familial as well as sporadic forms of Parkinson's disease (PD), a neurodegenerative disease characterized by dysfunction and degeneration of dopaminergic and other types of neurons. The molecular and cellular mechanisms underlying LRRK2 action remain poorly defined. Here, we show that LRRK2 controls synaptic morphogenesis at the Dr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید